1,672
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database

, , , , , , & show all
Pages 519-526 | Received 28 Jan 2021, Accepted 11 Aug 2021, Published online: 24 Nov 2021

References

  • GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923–1994.
  • Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967.
  • Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, Middle-, and low-income countries. JAMA. 2013;310(9):959–968.
  • Ödesjö H, Adamsson Eryd S, Franzén S, et al. Visit patterns at primary care centres and individual blood pressure level – a cross-sectional study. Scand J Prim Health Care. 2019;37(1):53–59.
  • Minor D, Wofford M, Wyatt SB. Does socioeconomic status affect blood pressure goal achievement? Curr Hypertens Rep. 2008;10(5):390–397.
  • Eriksson M, Carlberg B, Pennlert J, et al. Time trends and socioeconomic differences in blood pressure levels: the Northern Sweden MONICA study 1994-2014. Eur J Prev Cardiol. 2017;24(14):1473–1481.
  • Satoh A, Arima H, Ohkubo T, et al. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010. J Hypertens. 2017;35(2):401–408.
  • Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341–378.
  • Hasselstrom J, Zarrinkoub R, Holmquist C, et al. The Swedish primary care cardiovascular database (SPCCD): 74,751 hypertensive primary care patients. Blood Press. 2013;23:116–125.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
  • Brooke HL, Talback M, Hornblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–773.
  • Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
  • Ludvigsson JF, Svedberg P, Olén O, et al. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–437.
  • Qvarnstrom M, Kahan T, Kieler H, et al. Persistence to antihypertensive drug treatment in Swedish primary healthcare. Eur J Clin Pharmacol. 2013;69(11):1955–1964.
  • Ostchega Y, Hughes JP, Wright JD, et al. Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults? Am J Hypertens. 2008;21(2):159–165.
  • Shahu A, Herrin J, Dhruva SS, et al. Disparities in socioeconomic context and association with blood pressure control and cardiovascular outcomes in ALLHAT. J Am Heart Assoc. 2019;8(15):e012277.
  • Andersson T, Pikkemaat M, Schiöler L, et al. The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: a cohort study from the Swedish primary care cardiovascular database (SPCCD). PLoS One. 2020;15(8):e0237107.
  • Carlsson AC, Wändell PE, de Faire U, et al. Prevalence of hypertension in immigrants and Swedish-born individuals, a cross-sectional study of 60-year-old men and women in Sweden. J Hypertens. 2008;26(12):2295–2302.
  • Modesti PA, Reboldi G, Cappuccio FP, et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One. 2016;11(1):e0147601.
  • Gu A, Yue Y, Desai RP, et al. Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension: the national health and nutrition examination survey, 2003 to 2012. Circ Cardiovasc Qual Outcomes. 2017;10:e003166.
  • Marques-Vidal P, Vollenweider P, Waeber G, et al. The prevalence and management of cardiovascular risk factors in immigrant groups in Switzerland. Int J Public Health. 2012;57(1):63–77.
  • Andersson T, Pikkemaat M, Schiöler L, et al. Country of birth and mortality risk in hypertension with and without diabetes: the Swedish primary care cardiovascular database. J Hypertens. 2020;39:1155–1162.
  • Leng B, Jin Y, Li G, et al. Socioeconomic status and hypertension: a meta-analysis. J Hypertens. 2015;33(2):221–229.
  • Sivén SS, Niiranen TJ, Aromaa A, et al. Social, lifestyle and demographic inequalities in hypertension care. Scand J Public Health. 2015;43(3):246–253.
  • Supiyev A, Kossumov A, Utepova L, et al. Prevalence, awareness, treatment and control of arterial hypertension in Astana, Kazakhstan. A cross-sectional study. Public Health. 2015;129(7):948–953.
  • Dorobanţu M, Darabont R, Ghiorghe S, et al. Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys. J Hypertens. 2014;32(1):39–47.
  • Yang F, Qian D, Liu X. Socioeconomic disparities in prevalence, awareness, treatment, and control of hypertension over the life course in China. Int J Equity Health. 2017;16(1):100.
  • Holmquist C, Hasselström J, Bengtsson Boström K, et al. Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database. J Hypertens. 2017;35(10):2102–2108.
  • Tahkola A, Korhonen P, Kautiainen H, et al. Personalized text message and checklist support for initiation of antihypertensive medication: the cluster randomized, controlled check and support trial. Scand J Prim Health Care. 2020;38(2):201–209.
  • Ljungman C, Kahan T, Schioler L, et al. Gender differences in antihypertensive drug treatment: results from the Swedish primary care cardiovascular database (SPCCD). J Am Soc Hypertens. 2014;8(12):882–890.
  • Wallentin F, Wettermark B, Kahan T. Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity. J Clin Hypertens. 2018;20(1):106–114.
  • Choi HM, Kim HC, Kang DR. Sex differences in hypertension prevalence and control: analysis of the 2010–2014 Korea national health and nutrition examination survey. PLoS One. 2017;12(5):e0178334.
  • Foti K, Wang D, Appel LJ, et al. Hypertension awareness, treatment, and control in US adults: trends in the hypertension control cascade by population subgroup (national health and nutrition examination survey, 1999–2016). Am J Epidemiol. 2019;188(12):2165–2174.
  • Rea F, Mella M, Monzio Compagnoni M, et al. Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study. J Hypertens. 2020;38(1):142–149.